Study of TS-1 as 2nd Line Treatment in Patients With Advanced Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Tegafur Gimeracil Oteracil Potassium Capsule
Sponsor: Chinese Academy of Medical Sciences
Collaborators: Peking University Cancer Hospital & Institute|Beijing Chao Yang Hospital|Chinese PLA General Hospital|China-Japan Friendship Hospital|Tianjin Medical University Cancer Institute and Hospital|Hebei Tumor Hospital